MegaMD Co., Ltd.

MegaMD Co., Ltd.

KKRX:133750
1,297.00
KRW
-39.00
(-2.92%)
228.39EPS
6.10P/E
30.75BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3,863.54
3,951.63
2,913.25
3,293.04
3,598.04
3,695.45
3,770.62
3,595.31
2,929.28
1,634.56
1,653.07
1,566.99
1,504.87
Basic EPS, GAAP
265
517
91
-134
53
19
224
301
96
-145
171.39
126.38
228.39
Free Cash Flow per Basic Share
128.18
760.32
-281.86
97.74
578.65
335.07
557.92
713.81
-454.77
-64.77
366.86
170.84
- -
Dividend per Share
- -
- -
- -
101.41
50.24
48.36
49.77
99.91
150.46
- -
- -
60
- -
Book Value per Share
1,976.26
2,983.72
2,997.12
2,760.7
2,759.56
2,635.38
2,804.29
3,016.77
2,978.11
2,819.67
2,979.78
3,007.44
3,104.38
Tangible Book Value per Share
1,845.75
2,860.47
2,429.43
2,264.51
2,196.29
2,175.8
2,308.47
2,750.32
2,696.95
2,617.57
2,784.65
2,845.59
2,942.27
Basic Weighted Avg Shares
17
17
21
21
21
22
22
22
22
22
22
22
22
Sales/Revenue/Turnover
64,821
66,936
60,076
69,202
75,328
80,374
82,440
79,435
64,468
36,041
36,491
34,591
33,245
Operating Margin (%)
11.03
15.48
3.47
-3.05
2.78
-1.05
8.91
9.71
4.05
-10.82
6.34
5.47
7.07
Depreciation Expense
1,995
2,099
3,293
4,771
4,807
12,522
12,169
11,776
9,272
5,909
5,094
4,600
5,065
Net Income, GAAP
4,446
8,757
1,877
-2,816
1,110
413
4,897
6,650
2,113
-3,197
3,783
2,790
5,046
Effective Tax Rate (%)
39.49
25.5
25.73
- -
45.92
69.13
32.79
16.19
19.99
- -
21.35
26.3
24.19
Profit Margin (%)
6.86
13.08
3.12
-4.07
1.47
0.51
5.94
8.37
3.28
-8.87
10.37
8.07
15.18
Working Capital
-930
16,399
2,038
-1,746
-4,725
-9,109
4,263
21,773
28,468
30,430
24,672
26,635
34,751
LT Debt
- -
1,320
- -
- -
- -
3,346
3,769
2,154
4,058
2,246
2,017
1,302
937
Total Equity
41,317
61,375
62,586
57,161
57,191
57,327
61,861
66,595
65,742
62,244
65,779
66,389
68,529
Return on Invested Capital (%)
- -
14.35
2.42
- -
1.76
-0.42
6.81
8.66
2.15
- -
2.55
1.9
2.42
Return on Capital (%)
- -
17.65
4.16
- -
1.95
0.19
7.38
9.46
3.19
- -
5.77
4.2
7.41
Return on Common Equity (%)
- -
17.33
3.03
-4.65
1.91
0.72
8.21
10.35
3.19
-5
5.91
4.22
7.52

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,902
1,567
1,118
LT Borrowings
- -
- -
- -
LT Finance Leases
1,302
1,065
937
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
22
22
22
Market Capitalization
40,066
39,404
30,750

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
41,668
46,664
51,016
Cash, Cash Equivalents & STI
37,325
43,141
47,861
Accounts Receivable, Net
899
896
771
Inventories
394
404
350
Total Current Liabilities
15,033
17,456
16,265
Payables & Accruals
- -
- -
- -
ST Debt
1,902
1,567
1,118
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.92%
1.53%
0.93%
Free Cash Flow
-70.35%
-188.08%
-53.43%
Net Income, GAAP
2.6%
-105.67%
-26.26%
Sales/Revenue/Turnover
-4.75%
-14.11%
-5.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
8,709
10,729
9,940
7,114
36,491
2025
8,379
9,760
9,323
7,128
34,591
2026
7,782
9,011
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
42
43
40.71
16.65
171.39
2025
-8.79
64.23
98.52
-27.58
126.38
2026
85.41
72
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
60
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yong-Gook Yoon
Full Time Employees
155
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Seoul South Korea
IPO Date
Dec 21, 2015
Business
MegaMD Co., Ltd. is a South Korea-based education services company that specializes in providing online lecture content, offline academy instruction, educational publishing, and comprehensive test preparation solutions for professional graduate school entrance examinations and adult professional certifications. A subsidiary of Megastudy Holdings Co., Ltd., the company operates primarily across South Korea, catering to adult learners, university students, and career-seeking professionals. The company delivers its core educational products and services across specialized segments and dedicated brand portfolios, which include: legal education services provided under the Mega Law School and Mega Lawyers brands, offering preparatory lectures for the Legal Education Eligibility Test (LEET), law school admission consulting, bar examination preparation courses, and legal practitioner training; medical and pharmaceutical education services, comprising prep courses for the Medical and Dental Education Eligibility Test (M·DEET), pharmacy preliminary qualification examinations for foreign graduates, and national pharmacist licensing exams; professional license preparation programs, including specialized curricula for certified patent attorneys (Mega Patent Attorney), certified public tax accountants (Mega Tax Accountant), and certified public accountants; real estate and vocational qualification services delivered under the Mega Land brand, providing comprehensive courses for certified real estate agents and property appraisers; lifelong learning and degree accreditation programs via Mega Remote Lifelong Education Center and Mega Future Lifelong Education Center, which provide credit bank system courses, lifelong education certifications, and vocational skills development; and educational publishing and digital services, supplying official textbooks, proprietary mock examination sets, and learning management systems. In recent years, following structural changes in the domestic education system—notably the nationwide discontinuation of the Pharmacy Education Eligibility Test (PEET) and the reversion to a six-year undergraduate pharmacy admissions model—the company has implemented a strategic shift to diversify its business portfolio and reduce revenue reliance on traditional medical and pharmacy school entrance testing. MegaMD has expanded its presence across high-demand adult professional qualification markets, launching and scaling dedicated training tracks for patent attorneys, tax accountants, and accountants, while rolling out specialized programs for overseas pharmacy graduates seeking domestic licensing. Furthermore, the company has incorporated artificial intelligence-driven learning tools, such as automated lecture summaries, keyword extraction, and personalized mock test diagnostics, into its digital lecture platforms. MegaMD has also continued optimizing its hybrid delivery infrastructure, enhancing digital-first distance learning capabilities while consolidating direct offline academy operations across key academic hubs including Gangnam and Sinchon in Seoul. MegaMD Co., Ltd. was founded in September 2008 and is headquartered in Seoul, South Korea. The company is listed on the KOSDAQ market of the Korea Exchange under the ticker 133750.